Monday, 13 January 2020
Professor Kevin Shakesheff has been appointed as Chair of the Board of the National Centre for the Replacement Refinement and Reduction of Animals in Research (NC3Rs). He will help to shape the NC3Rs strategy and promote the UK’s position at the forefront of 3Rs research and development.
NC3Rs is a leading independent scientific organisation dedicated to replacing, refining and reducing the use of animals in research and testing (the 3Rs). It supports the UK science base by driving and funding innovation and technological developments that minimise the need for animals in research and testing, and lead to improvements in welfare where animals continue to be used. It funds research, supports training and development, and stimulates changes in regulations and practice. Primarily funded by Government, the NC3Rs is also supported by the charitable and private sectors. It works with scientists in universities and industry in the UK and internationally.
Kevin is Chair of the University’s Animal Welfare and Ethical Review Body. He is Professor of Advanced Drug Delivery and Tissue Engineering and Director of the UK Regenerative Medicine Platform Hub for Acellular Technologies. Kevin has published over 250 papers, focusing on regenerative medicine and applying tissue engineered models in vitro in drug discovery and safety profiling, technologies that are key to advancing the 3Rs.
Kevin replaces Professor Stephen Holgate CBE, University of Southampton, whose tenure as Board Chair ends after six years.
I鈥檓 very pleased to be appointed as the NC3Rs Board Chair. I remember the NC3Rs being set up 15 years ago and it has been very interesting watching it grow into an organisation that is recognised nationally and internationally for its science and impact on the 3Rs. There are an increasing number of cutting-edge technologies available with 3Rs potential and I am very much looking forward to working with the NC3Rs team and Board to champion these.
Dr Vicky Robinson CBE, NC3Rs Chief Executive, said, "I would like to take this opportunity to thank our outgoing Chair, Professor Stephen Holgate for all of his support. Stephen is a hard act to follow, but I am excited about Kevin’s appointment. Kevin has a long-standing commitment to the 3Rs and shares the NC3Rs vision of working collaboratively to deliver meaningful 3Rs impacts that benefit animals, science and industry."
The Medical Research Council (MRC) is the major core funder of the NC3Rs. Professor Fiona Watt, Executive Chair of the MRC, said, "The MRC is highly committed to the principles of the 3Rs and is proud to provide core funding for the NC3Rs. We are delighted that Kevin has been appointed as the NC3Rs Board Chair and wish him every success in helping the NC3Rs deliver its mission, and in driving forward the vital work to maintain the UK’s position as a world leader in 3Rs research and development."
Watch the video below to learn more about what Kevin plans to achieve in his tenure as NC3Rs Board Chair.
Story credits
Further information can be found at: .
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.